The Technical Analyst
Select Language :
Synaptogenix, Inc. [SNPX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Synaptogenix, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Synaptogenix, Inc. is listed at the  Exchange

-5.30% $0.188

America/New_York / 28 mar 2024 @ 16:00


Synaptogenix, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 3.82 mill
EPS: -0.850
P/E: -0.220
Earnings Date: May 29, 2024
SharesOutstanding: 20.39 mill
Avg Daily Volume: 0.801 mill
RATING 2024-03-28
A
Buy
RATINGS
Rating CashFlow: Neutral
Return On Equity: Buy
Return On Asset: Strong Buy
DE: Sell
P/E: Strong Buy
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debtn/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.220 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.04x
Company: PE -0.220 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.158 - 0.218

( +/- 16.00%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-03-29 Schechter Jonathan Buy 20 000 Stock Option (Right to Buy)
2023-03-29 Singer William S. Buy 20 000 Stock Option (Right to Buy)
2023-03-29 Bernstein Bruce Buy 20 000 Stock Option (Right to Buy)
2023-03-29 Silverman Joshua Buy 20 000 Stock Option (Right to Buy)
2022-12-16 Singer William S. Sell 27 000 Common Stock, par value $0.0001 per share
INSIDER POWER
75.03
Last 67 transactions
Buy: 1 842 000 | Sell: 283 116

Forecast: 16:00 - $0.190

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.190
Forecast 2: 16:00 - $0.190
Forecast 3: 16:00 - $0.190
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.188 (-5.30% )
Volume 0.122 mill
Avg. Vol. 0.801 mill
% of Avg. Vol 15.18 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Synaptogenix, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Synaptogenix, Inc.

RSI

Intraday RSI14 chart for Synaptogenix, Inc.

Last 10 Buy & Sell Signals For SNPX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Synaptogenix, Inc.

SNPX

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.

Last 10 Buy Signals

Date Signal @
PLUUSDMar 29 - 03:005.94
MUSEUSDMar 29 - 02:5818.86
TONUSDMar 29 - 02:534.87
GLMUSDMar 29 - 02:58$0.690
YAKUSDMar 29 - 02:57834.25
UMAUSDMar 29 - 02:57$4.31
DIGGUSDMar 29 - 02:54891.16
BFICUSDMar 29 - 02:549.82
GRPUSDMar 29 - 02:5316.49
DPXUSDMar 29 - 02:4542.45

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.